Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BH-30643 |
Trade Name | |
Synonyms | BH 30643|BH30643 |
Drug Descriptions |
BH-30643 is a reversible, mutant-selective inhibitor of EGFR and ERBB2 (HER2) with activity against EGFR exon 20 insertions, EGFR exon 19 deletions, EGFR T790M, EGFR L858R, and EGFR C797S, which potentially inhibits tumor cell proliferation (Cancer Res (2025) 85 (8_Supplement_1): 5608). |
DrugClasses | EGFR Exon 20 Insertion Inhibitor 15 EGFR Inhibitor 4th gen 19 HER2 Inhibitor 44 |
CAS Registry Number | NA |
NCIT ID | C215012 |